Mustang Bio Announces Pricing of $4 Million Public
WORCESTER, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
Source: globenewswire.com
📰 Jaclyn Jaffe News
Jaclyn Jaffe News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jaclyn Jaffe. Real-time updates on events, politics, business and more.
Journey Medical Corporation to Present at the Planet
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage...
Source: globenewswire.com
Avenue Therapeutics to Present BAER-101 Preclinical Data at
BAER-101 demonstrated full suppression of seizure activity in SynapCells GAERS model of absence epilepsy, a proven indicator of efficacy in anti-seizure...
United States Amy Chappell Jaclyn Jaffe Baergic Bio American Society For Experimental Neurotherapeutics Avenue Therapeutics Inc
Source: globenewswire.com
Journey Medical Corporation Announces Presentation of Data
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that...
Source: globenewswire.com
Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
MIAMI, Dec. 29, 2023 -- Fortress Biotech, Inc. , an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic...
United States Tony Plohoros Jaclyn Jaffe Fred Hutchinson Cancer Center Fortress Or Company Research Hospital
Source: marketscreener.com
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting - Fortress Biotech (NASDAQ:FBIO), Avenue Therapeutics (NASDAQ:ATXI)
MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for the
Source: benzinga.com
Fortress Biotech Announces Closing of $10.0 Million Public Offering - Fortress Biotech (NASDAQ:FBIO)
MIAMI, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress" or "Company"), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or
United States Tony Plohoros Jaclyn Jaffe Company Contact Roth Capital Partners Jude Children Research Hospital
Source: benzinga.com
Fortress Biotech Reports Third Quarter 2023 Financial
Total consolidated net revenue was $34.8 million in the third quarter of 2023, a 100% increase from total consolidated net revenue of $17.4 million in the...
Source: globenewswire.com
Journey Medical Corporation (NASDAQ:DERM) Q3 2023 Earnings Call Transcript
Journey Medical Corporation (NASDAQ:DERM) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Ladies and gentlemen, thank you for standing by. Good afternoon. And welcome to Journey Medical’s Third Quarter 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Participants of this call are […]
Source: yahoo.com
Fortress Biotech Announces Pricing of $10.0 Million Public
MIAMI, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused...
United States Tony Plohoros Jaclyn Jaffe Securities Exchange Fortress Or Company Exchange Commission
Source: globenewswire.com